Compounds > sch 58261

Page last updated: 2024-09-05

sch 58261 and 4-hydroxy-3-(methylthio)-4,5,6,7-tetrahydro-2-benzothiophene-1-carbohydrazide

sch 58261 has been researched along with 4-hydroxy-3-(methylthio)-4,5,6,7-tetrahydro-2-benzothiophene-1-carbohydrazide in 1 studies

Compound Research Comparison

Studies (sch 58261)	Trials (sch 58261)	Recent Studies (post-2010) (sch 58261)	Studies (4-hydroxy-3-(methylthio)-4,5,6,7-tetrahydro-2-benzothiophene-1-carbohydrazide)	Trials (4-hydroxy-3-(methylthio)-4,5,6,7-tetrahydro-2-benzothiophene-1-carbohydrazide)	Recent Studies (post-2010) (4-hydroxy-3-(methylthio)-4,5,6,7-tetrahydro-2-benzothiophene-1-carbohydrazide)
46	0	14	5	0	0

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Daly, JW; Jacobson, KA; Melman, N; Padgett, WL; Shi, D; Siddiqi, SM; van Rhee, AM	1

Other Studies

1 other study(ies) available for sch 58261 and 4-hydroxy-3-(methylthio)-4,5,6,7-tetrahydro-2-benzothiophene-1-carbohydrazide

Article	Year
Tetrahydrobenzothiophenone derivatives as a novel class of adenosine receptor antagonists. Journal of medicinal chemistry, 1996, Jan-19, Volume: 39, Issue:2 Topics: Animals; Binding Sites; Humans; Male; Mice; Models, Molecular; Motor Activity; Purinergic P1 Receptor Antagonists; Rats; Structure-Activity Relationship; Thiophenes	1996